Browse Category

NYSE:UNH News 22 October 2025 - 30 November 2025

UnitedHealth Group (UNH) Stock Outlook Before December 1, 2025: Can Bulls Look Past DOJ Risk and Medicare Pressures?

UnitedHealth Group (UNH) Stock Outlook Before December 1, 2025: Can Bulls Look Past DOJ Risk and Medicare Pressures?

As Wall Street gets ready for trading on Monday, December 1, 2025, UnitedHealth Group Incorporated (NYSE: UNH) heads into December as one of the most closely watched – and most controversial – names in the Dow. After Friday’s shortened session on November 28, UnitedHealth closed at $329.77, with after‑hours trading edging down to $329.50. That leaves the stock about 47% below its 52‑week high of $622.83 and still well above its recent low near $234.60.StockAnalysis+1 Fresh analysis over the weekend shows year‑to‑date losses of roughly 34–35% and a one‑year total shareholder return of about –44–45%, even after a roughly 3%
30 November 2025
UnitedHealth Group (UNH) Stock Today, November 24, 2025: ACA Subsidy Relief After a 50% Crash

UnitedHealth Group (UNH) Stock Today, November 24, 2025: ACA Subsidy Relief After a 50% Crash

UnitedHealth Group Incorporated (NYSE: UNH) shares are edging higher today as investors digest fresh policy headlines out of Washington and a wave of new analysis explaining how the stock managed to lose roughly half its value over the past year. By early afternoon, UNH is trading around $322 per share, up about 0.6% on the day, with an intraday range near $318–$329 and a market value just under $292 billion.StockAnalysis That’s still almost 50% below its 52‑week high of about $623, underscoring how severe 2025’s selloff has been.StockAnalysis+1 At the same time, a new Reuters report that the Trump administration
24 November 2025
UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

UNH Stock Forecast for 2026: Can UnitedHealth Survive the DOJ Storm and Medicare Cuts? (Updated November 15, 2025)

UnitedHealth Group’s UNH stock has become one of the most controversial names in the Dow in 2025. After a brutal sell-off driven by a massive cyberattack, rising medical costs and intensifying federal investigations, the stock is trying to stage a comeback — but faces a regulatory and political overhang unlike anything in its history. This analysis pulls together the latest November 2025 news and presents a forward-looking UNH stock forecast for 2026–2027, based on currently available public information. It is not financial advice, but a structured view of the opportunity and the risks for investors following UnitedHealth. UNH stock today:
Stocks to Buy Today (Oct. 22, 2025): Top Picks as Markets Near Record Highs

Stocks to Buy Today (Oct. 22, 2025): Top Picks as Markets Near Record Highs

Market News & Today’s Financial Outlook Stocks are starting today on cautiously optimistic footing. Futures were little changed this morning after a batch of earnings delivered both relief and warnings. Netflix shocked investors with a rare earnings miss, sending its stock down ~6–7% in pre-market tradingreuters.com. And chipmaker Texas Instruments sank nearly 9% after issuing a bleak sales forecast, which in turn dragged down other semiconductor namesreuters.com. Those disappointments put a slight chill on Nasdaq futures. “We’re at a bit of a point of indecision, where nobody feels particularly strongly about anything,” noted Michael Green of Simplify Asset Management, observing
1 5 6 7

Stock Market Today

Costco stock price retakes $1,000 — what traders are watching before Monday

Costco stock price retakes $1,000 — what traders are watching before Monday

7 February 2026
Costco closed Friday up 1.2% at $1,001.16, regaining the $1,000 level as about 2.36 million shares changed hands. January net sales rose 9.3% to $21.33 billion, with comparable sales up 7.1% and online sales surging 34.4%. Wells Fargo raised its price target to $950, maintaining a neutral rating. The next earnings call is set for March 5.
Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

7 February 2026
Johnson & Johnson shares rose 0.9% to $239.99 Friday after a New Jersey appeals court disqualified Beasley Allen from state talc cases, citing improper coordination with a former J&J attorney. The ruling affects about 3,600 state lawsuits, while a related federal motion is pending. J&J also reported early 12-month pilot data for its investigational AFib device at a cardiology meeting.
Go toTop